Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar BiLoandWise (30.55) Submitted: 5/5/2008 7:24:42 AM : Outperform Start Price: $80.93 CVD Score: -39.60

A TMFEldrehad Monthly pick.

Featured Broker Partners


Advertisement